peptidream - Robuta Search

https://www.globenewswire.com/de/news-release/2025/10/15/3166805/0/en/Curium-Group-PeptiDream-and-PDRadiopharma-Enroll-First-Patient-to-Registrational-Clinical-Trial-of-64Cu-PSMA-I-T-for-Prostate-Cancer-in-Japan.html Curium Group, PeptiDream and PDRadiopharma Enroll First curium group enroll first https://www.globenewswire.com/de/news-release/2026/02/04/3231755/0/en/Curium-Group-PeptiDream-and-PDRadiopharma-Enroll-First-Patient-to-Registrational-Clinical-Trial-of-Lu-PSMA-I-T-for-Prostate-Cancer-in-Japan.html Curium Group, PeptiDream and PDRadiopharma Enroll First A Registrational Phase 2 clinical trial has been initiated in Japan for patients with PSMA-positive metastatic castration-resistant prostate cancer... curium group enroll first https://www.benzinga.com/general/biotech/21/07/22246992/peptidream-inks-2-2b-deal-to-broaden-alnylams-sirna-delivery-scope PeptiDream Inks $2.2B Deal To Broaden Alnylam's siRNA Delivery Scope - Alnylam Pharmaceuticals... https://www.businesswire.com/news/home/20241212512779/en/PeptiDream-Announces-Second-Internal-Peptide-Radiopharmaceutical-Therapeutic-Program-Targeting-Claudin-18.2-for-the-Potential-Diagnosis-and-Treatment-of-Gastric-Cancer PeptiDream Announces Second Internal Peptide Radiopharmaceutical Therapeutic Program Targeting... We are planning to initiate human Ph0 imaging studies of 64Cu-PD-29875, highly-selective peptide-RI conjugate against Claudin 18.2, in 2025. therapeutic program announces second internal peptide